Biology, 2024 · DOI: 10.3390/biology13090703 · Published: September 7, 2024
The main challenge of axonal regeneration after traumatic injuries of the spinal cord consists of overcoming the activation of inhibitory pathways. Understanding the molecular mechanisms affecting regrowth (like the PKA/AMP, PI3K/Akt/mTOR pathways) and guidance cues (like neurotrophins) is thus essential. The use of gene therapy, tissue engineering, and small therapeutic molecules show a promising track to overcome inhibitory mechanisms to axonal regrowth.
Research into inhibitory and stimulatory factors has revealed potential strategies for therapeutic intervention in axonal regeneration.
Combination of direct reprogramming with other techniques and transcription factors could lead to novel treatments for SCI.
Collaborative efforts across disciplines will translate scientific discoveries into clinically effective treatments, improving patient outcomes and quality of life after SCI.